We are live on ! Find out more
ANIP icon

ANI Pharmaceuticals

157 hedge funds and large institutions have $379M invested in ANI Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 58 increasing their positions, 47 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more ownership

Funds ownership: 0%54% (+54%)

23% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 47

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

5% less capital invested

Capital invested by funds: $399M → $379M (-$19.5M)

8% less funds holding

Funds holding: 170157 (-13)

33% less call options, than puts

Call options by funds: $6.65M | Put options by funds: $9.9M

40% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 25

Holders
157
Holders Change
-13
Holders Change %
-7.65%
% of All Funds
3.92%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
15
Increased
58
Reduced
47
Closed
25
Calls
$6.65M
Puts
$9.9M
Net Calls
-$3.25M
Net Calls Change
-$3.46M
Name Holding Trade Value Shares
Change
Change in
Stake
Federated Hermes
101
Federated Hermes
Pennsylvania
$247K -$356K -5,822 -59%
LCM
102
Landscape Capital Management
New Jersey
$245K +$247K +4,034 New
TSS
103
Two Sigma Securities
New York
$233K -$48.3K -790 -17%
MSFP
104
Mark Sheptoff Financial Planning
Connecticut
$233K -$6.12K -100 -3%
CAM
105
Capstone Asset Management
Texas
$229K +$231K +3,770 New
VOYA Investment Management
106
VOYA Investment Management
Georgia
$216K
Janney Montgomery Scott
107
Janney Montgomery Scott
Pennsylvania
$216K +$16.3K +267 +8%
MFIMFI
108
Mesirow Financial Investment Management - Fixed Income
Illinois
$210K -$18.6K -305 -8%
CNAM
109
Campbell Newman Asset Management
Wisconsin
$207K +$22.8K +373 +12%
AG
110
Aperio Group
California
$203K +$17K +278 +9%
TRSOTSOK
111
Teachers Retirement System of the State of Kentucky
Kentucky
$182K
Bank of Montreal
112
Bank of Montreal
Ontario, Canada
$144K +$611 +10 +0.4%
CCMH
113
Cornerstone Capital Management Holdings
New York
$133K -$477K -7,800 -78%
Envestnet Asset Management
114
Envestnet Asset Management
Illinois
$117K -$41K -671 -26%
MERSOM
115
Municipal Employees' Retirement System of Michigan
Michigan
$110K -$107K -1,750 -49%
MSA
116
Mason Street Advisors
Wisconsin
$106K +$6.73K +110 +7%
BNP Paribas Financial Markets
117
BNP Paribas Financial Markets
France
$81.7K +$15.9K +260 +24%
AG
118
Advisor Group
Arizona
$71K -$2.57K -42 -3%
Victory Capital Management
119
Victory Capital Management
Texas
$61K -$1.53K -25 -2%
PI
120
PineBridge Investments
New York
$61K
SOADOR
121
State of Alaska Department of Revenue
Alaska
$52K +$52.6K +860 New
Royal Bank of Canada
122
Royal Bank of Canada
Ontario, Canada
$50K +$8.87K +145 +21%
LTFS
123
Ladenburg Thalmann Financial Services
Florida
$42K +$5.44K +89 +15%
CTC
124
Central Trust Company
Missouri
$38K -$5.81K -95 -13%
BlackRock
125
BlackRock
New York
$37K -$9.29K -152 -20%

ANIP Hedge Fund Activity: Q4 2016 in Review

157 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in ANI Pharmaceuticals (ANIP) for Q4 2016, worth a combined $379M — down 4.9% from $399M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of ANIP and 15 opened new positions — a net loss of 10 holders — while 47 trimmed existing stakes and 58 added.

The largest buyer was Perceptive Advisors, adding an estimated $15.6M. The largest seller was Consonance Capital Management, cutting an estimated $9.88M.

  • 157 institutional investors held ANI Pharmaceuticals (ANIP) as of Q4 2016, down from 170 in Q3 2016.
  • Funds reported $379M of ANI Pharmaceuticals stock for Q4 2016, down 4.9% quarter-over-quarter.
  • 15 funds opened new ANI Pharmaceuticals positions in Q4 2016 and 25 closed out, a net change of -10 holders.
  • The largest ANI Pharmaceuticals buyer in Q4 2016 was Perceptive Advisors, an estimated $15.6M added.
  • The largest ANI Pharmaceuticals seller in Q4 2016 was Consonance Capital Management, an estimated $9.88M sold.

Based on aggregated 13F filings for Q4 2016.